Atlas Genetics has announced today that it has appointed Marc Jones as COO and CFO. Jones will lead Atlas' finance and operations functions, as well as new channel development. Prior to Atlas, Jones served as COO and CFO of Good Start Genetics, where he raised successive rounds of capital. Jones also served as CFO of T2 Biosystems, where he oversaw the company's public offering and helped drive commercialization of the company's first FDA IVD product. Previously, Jones was CFO at Crashlytics, Ivenix, and Chil Semiconductor.